Go Deep
Divi's Laboratories Limited
Divi's Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 16,371 | 84.7 | 14.74 | 0.00 | 9,305.00 |
| Sep 2026 | 16,301 | 84.5 | 14.81 | 0.00 | 9,352.00 |
| Sep 2026 | 15,930 | 87.1 | 15.23 | 0.00 | 9,613.50 |
| Sep 2026 | 16,087 | 86.3 | 15.13 | 0.00 | 9,550.00 |
| Sep 2026 | 16,087 | 86.3 | 15.13 | 0.00 | 9,550.00 |
| Sep 2026 | 16,086 | 87.0 | 15.13 | 0.00 | 9,550.00 |
| Sep 2026 | 16,086 | 87.0 | 15.13 | 0.00 | 9,550.00 |
| Oct 2026 | 16,487 | 84.0 | 14.65 | 0.00 | 9,249.00 |
| Oct 2026 | 15,799 | 84.7 | 14.79 | 0.00 | 9,340.00 |
Divi's Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 30,800,000,000.0 | 28,310,000,000.0 | 26,040,000,000.0 | 24,100,000,000.0 |
| Net Profit | 9,020,000,000.0 | 7,510,000,000.0 | 5,830,000,000.0 | 5,450,000,000.0 |
| EPS | 34.0 | 28.3 | 22.0 | 20.5 |
Divi's Laboratories Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 104,760,000,000.0 | 93,250,000,000.0 | 77,960,000,000.0 | 76,650,000,000.0 |
| Net Profit | 25,680,000,000.0 | 21,910,000,000.0 | 16,000,000,000.0 | 18,240,000,000.0 |
| EPS | 96.8 | 82.5 | 60.3 | 68.7 |
Divi's Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 200,330,000,000.0 | 169,320,000,000.0 | 154,700,000,000.0 | 144,390,000,000.0 | — |
| Total Liabilities | 32,720,000,000.0 | 19,630,000,000.0 | 18,990,000,000.0 | 16,720,000,000.0 | — |
| Total Equity | 167,610,000,000.0 | 149,690,000,000.0 | 135,710,000,000.0 | 127,670,000,000.0 | — |
Owes vs Owns
Divi's Laboratories Limited owed ₹0.16 for every ₹1 it owned in Mar 2026, up from ₹0.12 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.16× | 0.12× | 0.12× | 0.12× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Divi's Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 16.2%Receivables 14.9%Inventory 19.7%Fixed assets (tangible) 43.8%Other assets 5.1%
How it's funded — Mar 2026
Payables 6.0%Other liabilities 10.3%Shareholders' equity 83.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,236.0 | 3,539.0 | 3,701.0 | 4,136.0 |
| Receivables | 2,984.0 | 2,731.0 | 2,156.0 | 1,793.0 |
| Inventory | 3,954.0 | 3,236.0 | 3,184.0 | 3,000.0 |
| Fixed assets (tangible) | 8,769.0 | 6,698.0 | 5,632.0 | 4,948.0 |
| Intangible assets | 6.0 | 4.0 | 4.0 | 5.0 |
| Long-term investments | 69.0 | 65.0 | 82.0 | 77.0 |
| Other assets | 1,015.0 | 659.0 | 711.0 | 480.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 2.0 | 0.0 | 0.0 |
| Long-term debt | 5.0 | 2.0 | 2.0 | 3.0 |
| Payables | 1,211.0 | 910.0 | 824.0 | 762.0 |
| Other liabilities | 2,056.0 | 1,049.0 | 1,073.0 | 907.0 |
| Shareholders' equity | 16,761.0 | 14,969.0 | 13,571.0 | 12,767.0 |
| Net tangible assets | 16,755.0 | 14,965.0 | 13,567.0 | 12,762.0 |
Divi's Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 27,380,000,000.0 | 16,530,000,000.0 | 12,610,000,000.0 | 24,590,000,000.0 | — |
| Investing Activities | -22,190,000,000.0 | -8,040,000,000.0 | -2,690,000,000.0 | -27,070,000,000.0 | — |
| Financing Activities | -8,040,000,000.0 | -7,990,000,000.0 | -7,990,000,000.0 | -7,970,000,000.0 | — |